EMERYVILLE, Calif.–(BUSINESS WIRE)–Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS) today announced that the compensation committee of the companys board of directors granted four new employees restricted stock units to acquire 44,500 shares of the companys…
